Patents by Inventor Katja SCHENKE-LAYLAND

Katja SCHENKE-LAYLAND has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Means and Methods to Treat Diabetes
    Publication number: 20220016219
    Abstract: The present application relates to a pharmaceutical composition for use in a method of treating diabetes in a human or animal subject in need thereof, to transplantation devices comprising the pharmaceutical composition of the present invention and to methods of treating diabetes using the pharmaceutical composition and transplantation device of the present invention.
    Type: Application
    Filed: July 28, 2021
    Publication date: January 20, 2022
    Applicant: Eberhard Karls Universitaet Tuebingen Medizinische Fakultaet
    Inventors: Shannon Layland, Katja Schenke-Layland, Garry Duffy, Svenja Hinderer, Aline Zbinden
  • METHOD AND DEVICE FOR PROVIDING A CELL LINE HAVING A DESIRED TARGET PROTEIN EXPRESSION
    Publication number: 20200096448
    Abstract: The invention relates to a method for providing a cell line having a desired target protein expression and to a device for selecting cell lines having a desired target protein expression.
    Type: Application
    Filed: April 6, 2018
    Publication date: March 26, 2020
    Inventors: Arnold GILLNER, Nadine NOTTRODT, Martin WEHNER, Dominik RIESTER, Anke BURGER-KENTISCHER, Monika BACH, Eva BRAUCHLE, Katja SCHENKE-LAYLAND, Benjamin GREINER, Andreas PIPPOW, Phuong-Ha NGUYEN, Katharina HOFER-SCHMITZ